US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

First Advantage Corp.

16.55

-0.7000-4.06%

Post-market: 16.590.0400+0.24%18:30 EDT

Volume:1.51M

Turnover:25.16M

Market Cap:2.87B

PE:-17.36

High:17.34

Open:17.18

Low:16.46

Close:17.25

Loading ...

Overview Company News Filings

First Advantage : Barclays Cuts to Equal-Weight From Overweight

THOMSON REUTERS

Lexeo Therapeutics Says Potential FA Cardiomyopathy Therapy Improves Cardiac Biomarkers

MT Newswires Live

Solid Biosciences to Participate at Upcoming Investor Conferences

Lexeo Therapeutics Announces Positive Interim Phase 1/2 Data for LX2006 in Friedreich Ataxia Cardiomyopathy Supporting Advancement to Registrational Study

First Advantage to Host Inaugural Investor Day on May 28, 2025

Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Binance's new project KernelDAO's investors include the liquidity provider Web3Port.

Lexeo Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights

Larimar Therapeutics Provides Nomlabofusp Development Update and Reports Fourth Quarter and Full Year 2024 Financial Results

FA should have seat on board of football regulator, say experts

Design Therapeutics Highlights Progress Across Lead GeneTAC® Programs and Reports Fourth Quarter and Full Year 2024 Financial Results

Analysts Have Conflicting Sentiments on These Industrial Goods Companies: Crane Company (CR) and First Advantage (FA)

Master Crypto Technical & Fundamental Analysis: Unlock Crypto Success

SLDB Stock Rallies 60% in a Month: Here's What You Should Know

Solid Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates

Solid Biosciences to Participate at Upcoming Investor Conferences

Millwall set to fight FA bid to extend Roberts ban for Mateta tackle

First Advantage to Participate in Wolfe Research FinTech Forum

Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

First Advantage Corp : Bmo Cuts Target Price to $22 From $24

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/FA/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"FA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FA\",,,,,undefined,":{"symbol":"FA","market":"US","secType":"STK","nameCN":"First Advantage Corp.","latestPrice":16.55,"timestamp":1750449600000,"preClose":17.25,"halted":0,"volume":1506117,"hourTrading":{"tag":"盘后","latestPrice":16.59,"preClose":16.55,"latestTime":"18:30 EDT","volume":37241,"amount":616402.77,"timestamp":1750458649393},"delay":0,"floatShares":79504572,"shares":173673549,"eps":-0.953074,"marketStatus":"Not Yet Opened","change":-0.7,"latestTime":"06-20 16:00:00 EDT","open":17.18,"high":17.34,"low":16.46,"amount":25159696.533936,"amplitude":0.051014,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.953074,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1750665600000},"marketStatusCode":0,"adr":0,"listingDate":1624420800000,"exchange":"NASDAQ","adjPreClose":17.25,"preHourTrading":{"tag":"盘前","latestPrice":17.25,"preClose":17.25,"latestTime":"09:25 EDT","volume":1182,"amount":20427.230622,"timestamp":1750425900028},"postHourTrading":{"tag":"盘后","latestPrice":16.59,"preClose":16.55,"latestTime":"18:30 EDT","volume":37241,"amount":616402.77,"timestamp":1750458649393},"volumeRatio":2.0773802177295018,"impliedVol":0.0889,"impliedVolPercentile":0.092},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FA\",,,,,undefined,":{"symbol":"FA","floatShares":79504572,"roa":"-1.23%","roe":"-13.59%","lyrEps":-0.742168,"volumeRatio":2.0773802177295018,"shares":173673549,"dividePrice":0,"high":17.34,"amplitude":0.051014,"preClose":17.25,"low":16.46,"week52Low":12.32,"pbRate":"2.25","psRate":"2.75","week52High":20.79,"institutionHeld":0,"latestPrice":16.55,"eps":-0.953074,"divideRate":0,"volume":1506117,"delay":0,"ttmEps":-0.953074,"open":17.18,"prevYearClose":18.73,"prevWeekClose":17.77,"prevMonthClose":17.12,"prevQuarterClose":14.09,"fiveDayClose":18.2,"twentyDayClose":17.3,"sixtyDayClose":14.01},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"FA\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2526301361","title":"First Advantage : Barclays Cuts to Equal-Weight  From Overweight","url":"https://stock-news.laohu8.com/highlight/detail?id=2526301361","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526301361?lang=en_us&edition=fundamental","pubTime":"2025-04-10 13:34","pubTimestamp":1744263273,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250410:nAZN3OSPBF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4535","BK4539","FA","BK4130"],"gpt_icon":0},{"id":"2525010099","title":"Lexeo Therapeutics Says Potential FA Cardiomyopathy Therapy Improves Cardiac Biomarkers","url":"https://stock-news.laohu8.com/highlight/detail?id=2525010099","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525010099?lang=en_us&edition=fundamental","pubTime":"2025-04-07 20:36","pubTimestamp":1744029406,"startTime":"0","endTime":"0","summary":"Lexeo Therapeutics  said Monday that interim data from two clinical trials showed that its gene therapy candidate LX2006 led to \"clinically significant\" improvements in cardiac biomarkers and functional measures across all dose cohorts for Friedreich ataxia, or FA, cardiomyopathy.The company said its phase 1/2 trial and Weill Cornell Medicine's phase 1a study also showed that the experimental treatment was associated with increased frataxin protein expression in all participants with cardiac biopsies.Chief Development Officer Sandi See Tai said the data show LX2006 exceeds the thresholds aligned with the US Food and Drug Administration to support accelerated approval in a registrational study expected to begin in early 2026.The company said it expects to begin enrollment in Q2 for the registrational study with a potential efficacy readout in 2027.Lexeo shares were up more than 14% in Monday's premarket activity.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LXEO","BK4535","FA","BK4539","BK4130","BK4139"],"gpt_icon":0},{"id":"2525178090","title":"Solid Biosciences to Participate at Upcoming Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2525178090","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525178090?lang=en_us&edition=fundamental","pubTime":"2025-04-07 20:00","pubTimestamp":1744027200,"startTime":"0","endTime":"0","summary":"CHARLESTOWN, Mass., April  07, 2025  (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB) (the “Company” or “Solid”), a life sciences company developing precision genetic medicines for neuromuscu","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/04/07/3056654/0/en/Solid-Biosciences-to-Participate-at-Upcoming-Investor-Conferences.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","FA","BK4130","BK4535","BK4139","SLDB"],"gpt_icon":0},{"id":"2525610018","title":"Lexeo Therapeutics Announces Positive Interim Phase 1/2 Data for LX2006 in Friedreich Ataxia Cardiomyopathy Supporting Advancement to Registrational Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2525610018","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525610018?lang=en_us&edition=fundamental","pubTime":"2025-04-07 18:00","pubTimestamp":1744020000,"startTime":"0","endTime":"0","summary":"Participants with abnormal left ventricular mass index (LVMI) at baseline achieved 25% mean reduction in LVMI by 12 months or sooner Clinically meaningful improvements in majority of participants acro","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/04/07/3056510/0/en/Lexeo-Therapeutics-Announces-Positive-Interim-Phase-1-2-Data-for-LX2006-in-Friedreich-Ataxia-Cardiomyopathy-Supporting-Advancement-to-Registrational-Study.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LXEO","BK4130","FA","BK4139","BK4539","BK4535"],"gpt_icon":0},{"id":"2524446738","title":"First Advantage to Host Inaugural Investor Day on May 28, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2524446738","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524446738?lang=en_us&edition=fundamental","pubTime":"2025-04-03 04:29","pubTimestamp":1743625740,"startTime":"0","endTime":"0","summary":"ATLANTA, April  02, 2025  (GLOBE NEWSWIRE) -- First Advantage Corporation (NASDAQ: FA), a leading provider of global software and data in the HR technology industry, today announced it will host its i","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/04/02/3054719/0/en/First-Advantage-to-Host-Inaugural-Investor-Day-on-May-28-2025.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4130","BK4181","BK4585","FA","HST","BK4539","BK4218","BK4535","BK4588"],"gpt_icon":0},{"id":"2524345118","title":"Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2524345118","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524345118?lang=en_us&edition=fundamental","pubTime":"2025-04-01 20:00","pubTimestamp":1743508800,"startTime":"0","endTime":"0","summary":"CHARLESTOWN, Mass., April 01, 2025  -- Solid Biosciences Inc. , a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, today announced grants of 43,374 restricted stock units  to three newly hired employees.The RSUs vest in four equal installments on each one-year anniversary of the grant date until the fourth anniversary of the grant date. Vesting of the equity awards is subject to the applicable employee’s continued service with the Company through each applicable vesting date.This grant was made pursuant to the Company’s 2024 Inducement Stock Incentive Plan and was made as an inducement material to the employee’s acceptance of employment with the Company in accordance with Nasdaq Listing Rule 5635.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/solid-biosciences-reports-inducement-grants-120000642.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2095319765.USD","TQQQ","NVIW.SI","IE00B3QW5Z07.USD","IE00B64PRP62.GBP","BK4112","BK4139","PSQ","QID","IE00BGHQF748.EUR","USJW.SI","BK4535","NDAQ","BK4585","SQQQ","SLDB","MNQmain","IE00BKPKM429.USD","BK4130","FA","BK4539","LU2210150020.SGD","QLD","BK4588","NQmain","USAW.SI",".IXIC","LU2210149790.SGD","TSYW.SI"],"gpt_icon":1},{"id":"2524319988","title":"Binance's new project KernelDAO's investors include the liquidity provider Web3Port.","url":"https://stock-news.laohu8.com/highlight/detail?id=2524319988","media":"Blockbeats","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524319988?lang=en_us&edition=fundamental","pubTime":"2025-04-01 17:46","pubTimestamp":1743500760,"startTime":"0","endTime":"0","summary":"BlockBeats News, April 1st, according to RootData, in this Binance Megadrop event, the upcoming project to be listed is KernelDAO (KERNEL), with liquidity provider Web3Port as one of the investors.Pre","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.theblockbeats.info//en/flash/287804","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"theblockbeats_live","symbols":["LU1815336091.USD","BK4539","IE00BZ199S13.USD","VC","BK4535","LU0757428866.USD","FA","BK4130","BK4124"],"gpt_icon":0},{"id":"2521746991","title":"Lexeo Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2521746991","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521746991?lang=en_us&edition=fundamental","pubTime":"2025-03-24 19:00","pubTimestamp":1742814000,"startTime":"0","endTime":"0","summary":"Additional alignment with FDA on LX2006 planned pivotal study including protein expression co-primary endpoint: based on improvements in LVMI across participants with abnormal LVMI at baseline, frataxin expression to be evaluated for any increase from baseline rather than numerical threshold. Interim update from cohort 1 of LX2020 HEROIC-PKP2 Phase 1/2 trial: observed 71% and 115% increases in PKP2 protein expression in first two post-treatment biopsies; first participant evaluated 6-months after dosing experienced 67% reduction in premature ventricular contractions . Completed enrollment of cohort 2 of LX2020 HEROIC-PKP2 Phase 1/2 trial; interim clinical data update expected in second half of 2025. LX2020 has been generally well tolerated with no treatment-related serious adverse events to date. Cash, cash equivalents and investments of $128.5 million expected to provide operational runway into 2027. NEW YORK, March 24, 2025  -- Lexeo Therapeutics, Inc. , a clinical stage genetic medi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/lexeo-therapeutics-reports-fourth-quarter-110000124.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4539","BK4130","BK4535","FA","LXEO","BK4139"],"gpt_icon":0},{"id":"2521469997","title":"Larimar Therapeutics Provides Nomlabofusp Development Update and Reports Fourth Quarter and Full Year 2024 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2521469997","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521469997?lang=en_us&edition=fundamental","pubTime":"2025-03-24 19:00","pubTimestamp":1742814000,"startTime":"0","endTime":"0","summary":"FDA stated in written correspondence for a START pilot program meeting that it is open to considering skin FXN concentration as a reasonably likely surrogate endpoint in support of an accelerated approval. FDA recommended measuring skin FXN concentrations to support evidence of effectiveness for accelerated approval pathway and acknowledged submitted data appear sufficient to support relationship between increased skin FXN concentrations and relevant tissues such as heart, dorsal root ganglia and skeletal muscle. Larimar is continuing discussions with FDA on the adequacy of the safety data set to support BLA submission. BLA seeking accelerated approval targeted for submission by year-end 2025. FDA and EMA feedback obtained on global Phase 3 study protocol; study planned to initiate in mid-2025. Dr. Ben-Maimon continued, “Our open label extension  study continues to advance, with some participants on daily treatment for up to one year. We continue to actively enroll study participants, ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/larimar-therapeutics-provides-nomlabofusp-development-110000420.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LRMR","BK4535","BK4130","FA","FXN","BK4539","PK","BK4139","BK4218","BK4181","LENZ"],"gpt_icon":0},{"id":"2520411107","title":"FA should have seat on board of football regulator, say experts","url":"https://stock-news.laohu8.com/highlight/detail?id=2520411107","media":"cityam","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520411107?lang=en_us&edition=fundamental","pubTime":"2025-03-20 08:01","pubTimestamp":1742428860,"startTime":"0","endTime":"0","summary":"MANCHESTER, ENGLAND – MARCH 02: A detailed view of the FA Cup badge on a Mitre Ultimax Pro Emirates FA Cup 2024/25 match ball prior to the Emirates FA Cup Fifth Round match between Manchester United and Fulham at Old Trafford on March 02, 2025 in Manchester, England.  The Football Association  should have a seat on the board of the independent football regulator, argues a new report by consultants LCP.LCP’s sports analytics and advisory unit calls for the incoming regulator to “work closely with the FA to guide its reform and build a modern football governance structure”.They add: “The focus should be on improving and strengthening the FA, not sidelining it. To support this, the regulator should offer the FA a seat on its board.”The regulator has in part been conceived to deal with matters that the FA and Premier League is seen as having failed to tackle effectively, such as financial redistribution and tests for prospective owners and directors of football clubs.","market":"nz","thumbnail":"https://www.cityam.com/wp-content/uploads/2025/03/GettyImages-2202849478.jpg?w=824&h=463&crop=1","type":0,"news_type":0,"thumbnails":["https://www.cityam.com/wp-content/uploads/2025/03/GettyImages-2202849478.jpg?w=824&h=463&crop=1"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.cityam.com/fa-should-have-seat-on-board-of-football-regulator-say-experts/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"cityam_highlight","symbols":["BK4130","FA","BK4539","BK4535"],"gpt_icon":0},{"id":"2518423852","title":"Design Therapeutics Highlights Progress Across Lead GeneTAC® Programs and Reports Fourth Quarter and Full Year 2024 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2518423852","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518423852?lang=en_us&edition=fundamental","pubTime":"2025-03-10 19:07","pubTimestamp":1741604820,"startTime":"0","endTime":"0","summary":"Initiated Phase 1 Single Ascending Dose Trial of DT-216P2 in Healthy Volunteers; Friedreich Ataxia (FA) Patient Dosing to Begin in mid-2025 Dosing Complete in DT-168 Phase 1 Healthy Volunteer Trial, w","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/10/3039587/0/en/Design-Therapeutics-Highlights-Progress-Across-Lead-GeneTAC-Programs-and-Reports-Fourth-Quarter-and-Full-Year-2024-Financial-Results.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4218","BK4566","LU1093756168.USD","LU2756315664.SGD","PD","LU0943347566.SGD","LU0320765646.SGD","IE00BWXC8680.SGD","BK4535","BK4504","BK4097","IE00B1XK9C88.USD","LU1778281490.HKD","LU0820561818.USD","LU0820562030.AUD","LU0823411888.USD","LU0079474960.USD","LU1551013342.USD","BK4023","LU1674673691.USD","BK4181","BK4534","LU0823434740.USD","LU1929549753.HKD","HD","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","LU1035775433.USD","DSGN","BK4539","LU0234572021.USD","LU0868494708.USD","LU0942090050.USD","LU2756315318.SGD","SG9999001440.SGD","LU1496350171.SGD","BK4505","LU1169590202.USD","LU1914381329.SGD","LENZ","LU1093756325.SGD","BK4585","LU0868494617.USD","LU1989772840.SGD","FA","BK4533","PK","PRGS","LU1162221912.USD"],"gpt_icon":0},{"id":"2518223058","title":"Analysts Have Conflicting Sentiments on These Industrial Goods Companies: Crane Company (CR) and First Advantage (FA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2518223058","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518223058?lang=en_us&edition=fundamental","pubTime":"2025-03-10 08:20","pubTimestamp":1741566037,"startTime":"0","endTime":"0","summary":"Companies in the Industrial Goods sector have received a lot of coverage today as analysts weigh in on Crane Company (CR – Research Report) and Fir...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-industrial-goods-companies-crane-company-cr-and-first-advantage-fa?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-industrial-goods-companies-crane-company-cr-and-first-advantage-fa?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4535","BK4539","CR","BK4161","FA","BK4130"],"gpt_icon":0},{"id":"2517112954","title":"Master Crypto Technical & Fundamental Analysis: Unlock Crypto Success","url":"https://stock-news.laohu8.com/highlight/detail?id=2517112954","media":"CoinMarketCap","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517112954?lang=en_us&edition=fundamental","pubTime":"2025-03-08 15:39","pubTimestamp":1741419563,"startTime":"0","endTime":"0","summary":"Imagine two traders sitting across from each other. One is glued to charts, analyzing price movements and patterns. The other is reading news, checking earnings reports, and studying economic trends.Well, both of them are. Traders rely on two main approaches—Technical Analysis  and Fundamental Analysis —to make trading decisions. Some swear by one, while others blend both to maximize their edge.If you’re struggling to decide which approach suits you, this guide will break it all down in a simple, practical way. Let’s dive in!Technical vs. Fundamental Analysis: Which One Should Traders Rely On?Technical Analysis  is like reading a stock’s mood swings. Traders analyze price charts, patterns, and indicators to predict future movements.Fundamental Analysis  is like checking a company’s health. It looks at financial statements, earnings, industry trends, and economic data to determine a stock’s real value.Example: If the 50-day EMA crosses above the 200-day EMA , it’s a strong buy signal.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://coinmarketcap.com/community/articles/67cbf42c23bed53226eb9f52/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"coinmarketcap_highlight","symbols":["IE00B775H168.HKD","RSI","LU2764263203.CNY","LU0786609619.USD","LU2087625088.SGD","APT.USD.HKCC","LU0109391861.USD","LU0823434740.USD","LU1551013425.SGD","TON.USD.HKCC","LU0006306889.USD","APT.USD.CC","IE00BQXX3C00.GBP","LU1983260115.SGD","LU0823421333.USD","LU2403377893.USD","FA","SG9999001077.SGD","LU0353189680.USD","LU0417517546.SGD","LU1815333072.USD","LU2092937148.SGD","LU2361044949.HKD","LU0823421416.USD","LU1974910355.USD","LU0234572021.USD","IE00BKDWB100.SGD","BK4581","LU0316494557.USD","LU2417539215.USD","TON.USD.CC","LU1084165304.USD","LU1691799644.USD","IE0004086264.USD","LU2764263039.SGD","SGXZ81514606.USD","LU1718418525.SGD","MA","LU0823434583.USD","LU0094547139.USD","IE0004091025.USD","IE0005OL40V9.USD","LU2552382215.SGD","IE00BQXX3F31.USD","IE0004445239.USD","LU2756315318.SGD","LU0957791311.USD","LU2063271972.USD","LU0170899867.USD"],"gpt_icon":0},{"id":"2517087432","title":"SLDB Stock Rallies 60% in a Month: Here's What You Should Know","url":"https://stock-news.laohu8.com/highlight/detail?id=2517087432","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517087432?lang=en_us&edition=fundamental","pubTime":"2025-03-07 22:13","pubTimestamp":1741356780,"startTime":"0","endTime":"0","summary":"Shares of Solid Biosciences SLDB have rallied 59.9% in the past month. The stock price increase was mainly due to positive initial data, announced in mid-Feb, fromthe early to mid-stage study of its next-generation gene therapy product candidate, SGT-003, for treating Duchenne muscular dystrophy .Interim biopsy data reported in the first three participants at day 90 showed an average microdystrophin expression of 110%, as measured by western blot, along with improvements in multiple biomarkers that are indicators of muscle health and resilience.In the past three months, shares of Solid Biosciences have gained 7.6% against the industry’s 1% decline.The initial data readout also showed encouraging early signals of potential cardiac benefit. SGT-003was well-tolerated in the first six DMD patients dosed. Adverse events were mostly mild to moderate in severity and consistent with those typically observed in AAV gene therapy.Currently,Sarepta TherapeuticsSRPT markets Elevidys as the only app","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/sldb-stock-rallies-60-month-141300442.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00B894F039.SGD","FA","RHHBY","BK4588","LU0234570918.USD","LU0889565916.HKD","IE0009355771.USD","LU0109394709.USD","BK4139","BK4535","BK4585","LU0320765992.SGD","SLDB","IE00BJT1NW94.SGD","IE00BFTCPJ56.SGD","SRPT","BK4533","IE00B19Z9Z06.USD","IE00B2B36J28.USD","BK4130","BK4532","03165","BIIB","IE0002141913.USD","IE00BJJMRZ35.SGD","BK4007","BK4539","IE00B19Z9P08.USD"],"gpt_icon":0},{"id":"2517113273","title":"Solid Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2517113273","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517113273?lang=en_us&edition=fundamental","pubTime":"2025-03-07 05:16","pubTimestamp":1741295760,"startTime":"0","endTime":"0","summary":"- Duchenne: Reported positive initial data from INSPIRE DUCHENNE trial of next-generation Duchenne gene therapy candidate, SGT-003; In mid-2025, Company plans to request a U.S. Food and Drug Administration  meeting to discuss potential accelerated approval pathways -. - FA: FDA Investigational New Drug  clearance for first-in-human clinical study of SGT-212 utilizing a dual route of administration to treat Friedreich’s ataxia ; Dosing of first participant anticipated in the second half of 2025 -. “Additionally, in the second half of 2025, we anticipate initiating a first-in-human clinical trial evaluating SGT-212, our second active neuromuscular gene therapy program to receive FDA IND clearanc","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/solid-biosciences-reports-fourth-quarter-211600112.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["GLP","BK4539","BK4535","BK4590","FA","BK4130","BK4144","SLDB","BK4139"],"gpt_icon":0},{"id":"2517891909","title":"Solid Biosciences to Participate at Upcoming Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2517891909","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517891909?lang=en_us&edition=fundamental","pubTime":"2025-03-05 21:00","pubTimestamp":1741179600,"startTime":"0","endTime":"0","summary":"CHARLESTOWN, Mass., March 05, 2025  -- Solid Biosciences Inc.  , a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, today announced participation in the following investor conferences:. Leerink Global Healthcare Conference – Miami, FLBo Cumbo, President and CEO, and Gabriel Brooks, M.D., Chief Medical Officer, will participate in a fireside chat on Wednesday, March 12, 2025, at 9:20 am ET.Barclays 27th Annual Global Healthcare Conference – Miami, FLMr. Cumbo and Dr. Brooks will participate in a fireside chat on Thursday, March 13, 2025, at 9:30 am ET.Solid is also a participating company at Wedbush Securities’ Cardiometabolic Conference taking place on Monday, March 10, 2025, in Miami, FL.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/solid-biosciences-participate-upcoming-investor-130000194.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4539","BK4130","SLDB","BK4139","FA","BK4535"],"gpt_icon":0},{"id":"2517091422","title":"Millwall set to fight FA bid to extend Roberts ban for Mateta tackle","url":"https://stock-news.laohu8.com/highlight/detail?id=2517091422","media":"cityam","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517091422?lang=en_us&edition=fundamental","pubTime":"2025-03-05 20:58","pubTimestamp":1741179513,"startTime":"0","endTime":"0","summary":"Millwall’s Liam Roberts could face a long ban for his challenge on Mateta Millwall are expected to contest the Football Association’s push for goalkeeper Liam Roberts to be given an extended ban for his challenge on Crystal Palace striker Jean-Philippe Mateta.The FA has asked a regulatory commission to increase Roberts’ ban from the standard three-match sanction for serious foul play on the grounds that it was “clearly insufficient”.Roberts was shown a red card after eight minutes of Saturday’s FA Cup fifth round match between the south London sides for a high challenge outside the penalty area that left Mateta needing 25 stitches to a lacerated ear.Palace chairman Steve Parish led condemnation of the incident, calling the challenge “the most reckless I’ve ever seen” and accusing Roberts of endangering Mateta’s life.","market":"fut","thumbnail":"https://www.cityam.com/wp-content/uploads/2025/03/GettyImages-2198356834-e1741179256179.jpg?w=824&h=463&crop=1","type":0,"news_type":0,"thumbnails":["https://www.cityam.com/wp-content/uploads/2025/03/GettyImages-2198356834-e1741179256179.jpg?w=824&h=463&crop=1"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.cityam.com/millwall-set-to-fight-fa-bid-to-extend-roberts-ban-for-mateta-tackle/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"cityam_highlight","symbols":["FA"],"gpt_icon":0},{"id":"2517829749","title":"First Advantage to Participate in Wolfe Research FinTech Forum","url":"https://stock-news.laohu8.com/highlight/detail?id=2517829749","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517829749?lang=en_us&edition=fundamental","pubTime":"2025-03-05 06:20","pubTimestamp":1741126800,"startTime":"0","endTime":"0","summary":"ATLANTA, March 04, 2025  -- First Advantage Corporation , a leading global provider of employment background screening, identity, and verification solutions, today announced that Company management will participate in a fireside chat at the Wolfe Research FinTech Forum in New York City at 8:00am ET on Tuesday, March 11, 2025. Company management will also host private meetings with investors throughout the day.First Advantage  is a leading global provider of employment background screening, identity, and verification solutions. Enabled by its proprietary technology, First Advantage delivers innovative services and insights that help customers mitigate risk and hire the best talent: employees, contractors, contingent workers, tenants, and drivers. Headquartered in Atlanta, Georgia, First Advantage performs screens in over 200 countries and territories on behalf of its 80,000 customers. For more information about how to hire smarter and onboard faster with First Advantage, visit the Compa","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/first-advantage-participate-wolfe-research-222000145.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NQmain","USJW.SI","FA",".IXIC","TSYW.SI","FET","BK4535","BK4179","NVIW.SI","BK4539","BK4130","MNQmain","PSQ","QID","USAW.SI","TQQQ","QLD","SQQQ"],"gpt_icon":1},{"id":"2517498979","title":"Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2517498979","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517498979?lang=en_us&edition=fundamental","pubTime":"2025-03-05 05:07","pubTimestamp":1741122420,"startTime":"0","endTime":"0","summary":"CHARLESTOWN, Mass., March 04, 2025  -- Solid Biosciences Inc. , a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, today announced a grant of 11,950 restricted stock units  to one newly hired employee.The RSUs vest in four equal installments on each one-year anniversary of the grant date until the fourth anniversary of the grant date. Vesting of the equity awards is subject to the employee’s continued service with the Company through each applicable vesting date.This grant was made pursuant to the Company’s 2024 Inducement Stock Incentive Plan and was made as an inducement material to the employee’s acceptance of employment with the Company in accordance with Nasdaq Listing Rule 5635.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/solid-biosciences-reports-inducement-grants-210700701.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4130","NDAQ","BK4539","USAW.SI","LU2210150020.SGD","USJW.SI","TSYW.SI","IE00B3QW5Z07.USD","BK4535","FA","QLD","SQQQ","BK4585","NQmain","BK4588","LU2095319765.USD","PSQ","BK4112","LU2210149790.SGD","NVIW.SI","IE00BKPKM429.USD","IE00B64PRP62.GBP",".IXIC","MNQmain","TQQQ","IE00BGHQF748.EUR","BK4139","QID","SLDB"],"gpt_icon":1},{"id":"2516163552","title":"First Advantage Corp : Bmo Cuts Target Price to $22 From $24","url":"https://stock-news.laohu8.com/highlight/detail?id=2516163552","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516163552?lang=en_us&edition=fundamental","pubTime":"2025-03-03 21:14","pubTimestamp":1741007659,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250303:nFWN3PM0W5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["FA","BK4130","BK4535","BK4539"],"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":3,"totalSize":114,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/FA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-08","symbol":"FA","fiscalQuarterEnding":"2025/03","expectedEps":0.09,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1746676800000,"reportTimeType":"pre","actualEps":0.14},{"market":"US","date":"2025-02-27","symbol":"FA","fiscalQuarterEnding":"2024/12","expectedEps":0.2,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1740632400000,"reportTimeType":"pre","actualEps":0.13},{"market":"US","date":"2024-11-12","symbol":"FA","fiscalQuarterEnding":"2024/09","expectedEps":0.23,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"pre","actualEps":0.21},{"market":"US","date":"2024-08-08","symbol":"FA","fiscalQuarterEnding":"2024/06","expectedEps":0.19,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1723089600000,"reportTimeType":"pre","actualEps":0.18},{"market":"US","date":"2024-05-09","symbol":"FA","fiscalQuarterEnding":"2024/03","expectedEps":0.16,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1715227200000,"reportTimeType":"pre","actualEps":0.14}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"FA\",market:\"US\",,,undefined,":[{"executeDate":"2023-08-18","recordDate":"2023-08-21","paymentDate":"2023-08-31","value":1.5,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"FA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2,"buy":0.2,"hold":0.6,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.2,"analysts":10,"updateTime":1746849600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/FA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"FA","date":"2025-06-20","current":-20.166188,"percent":0.269151,"low":-676.959328,"twenty":-23.510972,"median":39.037946,"eighty":73.126626,"high":704.194102,"avg":24.539659,"sd":247.575037,"marketCap":2995868720},"quantilePoints":[{"date":"2021-06-25","current":-69.598825,"twenty":-67.156035,"median":-65.514401,"eighty":-0.000033,"marketCap":3136610250},{"date":"2021-07-02","current":-67.835112,"twenty":-69.001876,"median":-67.665525,"eighty":-52.411527,"marketCap":3057125000},{"date":"2021-07-09","current":-67.529854,"twenty":-68.242123,"median":-67.037596,"eighty":-65.060656,"marketCap":3043367937},{"date":"2021-07-16","current":-63.731088,"twenty":-67.814762,"median":-65.766141,"eighty":-64.857151,"marketCap":2872168937},{"date":"2021-07-23","current":-64.273769,"twenty":-67.740143,"median":-65.749183,"eighty":-64.558676,"marketCap":2896625937},{"date":"2021-07-30","current":-66.512327,"twenty":-67.597689,"median":-65.514401,"eighty":-64.294119,"marketCap":2997511062},{"date":"2021-08-06","current":-62.442221,"twenty":-67.529854,"median":-65.138666,"eighty":-63.751438,"marketCap":2814083562},{"date":"2021-08-13","current":-146.718947,"twenty":-67.597689,"median":-65.189543,"eighty":-63.731088,"marketCap":3657850062},{"date":"2021-08-20","current":-146.780259,"twenty":-69.151113,"median":-65.623312,"eighty":-63.751438,"marketCap":3659378625},{"date":"2021-08-27","current":-143.775984,"twenty":-140.869809,"median":-66.512327,"eighty":-64.070263,"marketCap":3584479062},{"date":"2021-09-03","current":-142.856308,"twenty":-141.458401,"median":-66.664957,"eighty":-64.273769,"marketCap":3561550625},{"date":"2021-09-10","current":-147.945181,"twenty":-142.488438,"median":-67.343308,"eighty":-64.287336,"marketCap":3688421312},{"date":"2021-09-17","current":-136.418578,"twenty":-142.807259,"median":-67.699442,"eighty":-64.375521,"marketCap":3401051562},{"date":"2021-09-24","current":-125.689027,"twenty":-142.488438,"median":-68.343875,"eighty":-64.531542,"marketCap":3133553125},{"date":"2021-10-01","current":-125.259845,"twenty":-141.899846,"median":-72.31223,"eighty":-64.775748,"marketCap":3122853187},{"date":"2021-10-08","current":-128.99986,"twenty":-141.495188,"median":-120.170972,"eighty":-65.033522,"marketCap":3216095500},{"date":"2021-10-15","current":-126.424767,"twenty":-141.213154,"median":-125.137221,"eighty":-65.053873,"marketCap":3151895875},{"date":"2021-10-22","current":-131.820199,"twenty":-140.808497,"median":-125.903618,"eighty":-65.06744,"marketCap":3286409375},{"date":"2021-10-29","current":-114.652917,"twenty":-140.56325,"median":-126.118209,"eighty":-65.128491,"marketCap":2858411875},{"date":"2021-11-05","current":-129.061171,"twenty":-139.962395,"median":-125.474436,"eighty":-65.311646,"marketCap":3217624062},{"date":"2021-11-12","current":-589.248945,"twenty":-141.495188,"median":-126.424767,"eighty":-65.502641,"marketCap":3060559021},{"date":"2021-11-19","current":-544.805094,"twenty":-143.260965,"median":-127.191164,"eighty":-65.60153,"marketCap":2829717656},{"date":"2021-11-26","current":-527.145285,"twenty":-144.070281,"median":-127.405755,"eighty":-65.739007,"marketCap":2737992611},{"date":"2021-12-03","current":-499.478252,"twenty":-146.436913,"median":-127.834937,"eighty":-65.915378,"marketCap":2594290039},{"date":"2021-12-10","current":-502.127223,"twenty":-147.932919,"median":-128.63199,"eighty":-66.518929,"marketCap":2608048796},{"date":"2021-12-17","current":-500.066912,"twenty":-497.005879,"median":-128.815924,"eighty":-66.559086,"marketCap":2597347541},{"date":"2021-12-23","current":-534.503539,"twenty":-499.772582,"median":-129.061171,"eighty":-66.61408,"marketCap":2776211380},{"date":"2021-12-31","current":-560.404591,"twenty":-511.545787,"median":-130.318061,"eighty":-66.715833,"marketCap":2910741447},{"date":"2022-01-07","current":-529.794256,"twenty":-515.66641,"median":-131.820199,"eighty":-67.156761,"marketCap":2751751368},{"date":"2022-01-14","current":-520.081362,"twenty":-525.379304,"median":-135.80546,"eighty":-67.529854,"marketCap":2701302592},{"date":"2022-01-21","current":-482.112773,"twenty":-523.731055,"median":-137.522189,"eighty":-67.529854,"marketCap":2504093744},{"date":"2022-01-28","current":-481.818443,"twenty":-521.906208,"median":-139.116293,"eighty":-67.665524,"marketCap":2502564994},{"date":"2022-02-04","current":-484.467414,"twenty":-520.375692,"median":-140.77171,"eighty":-67.780844,"marketCap":2516323750},{"date":"2022-02-11","current":-503.304544,"twenty":-517.962184,"median":-141.568762,"eighty":-67.828329,"marketCap":2614163799},{"date":"2022-02-18","current":-482.995764,"twenty":-520.375692,"median":-142.794997,"eighty":-68.649134,"marketCap":2508679997},{"date":"2022-02-25","current":-471.516888,"twenty":-518.491979,"median":-143.65336,"eighty":-69.300351,"marketCap":2449058717},{"date":"2022-03-04","current":-466.513276,"twenty":-516.372802,"median":-144.082543,"eighty":-71.226868,"marketCap":2423069954},{"date":"2022-03-11","current":-464.452965,"twenty":-514.960017,"median":-144.756971,"eighty":-97.716642,"marketCap":2412368699},{"date":"2022-03-18","current":-516.5494,"twenty":-514.960017,"median":-146.780259,"eighty":-115.940463,"marketCap":2682957583},{"date":"2022-03-25","current":186.662864,"twenty":-514.960017,"median":-146.749603,"eighty":-71.226868,"marketCap":2996125630},{"date":"2022-04-01","current":192.761089,"twenty":-514.312491,"median":-144.205166,"eighty":-67.760494,"marketCap":3094008244},{"date":"2022-04-08","current":176.276824,"twenty":-513.664964,"median":-144.051887,"eighty":-66.98039,"marketCap":2829419304},{"date":"2022-04-14","current":177.229672,"twenty":-513.194036,"median":-143.65336,"eighty":-66.525531,"marketCap":2844713462},{"date":"2022-04-22","current":168.939897,"twenty":-512.54651,"median":-142.733685,"eighty":-65.502641,"marketCap":2711654284},{"date":"2022-04-29","current":165.458211,"twenty":-511.722386,"median":-141.476794,"eighty":-65.053873,"marketCap":2655769742},{"date":"2022-05-06","current":164.02856,"twenty":-511.074859,"median":-140.587775,"eighty":-64.375521,"marketCap":2632822422},{"date":"2022-05-13","current":48.465021,"twenty":-509.308879,"median":-139.085638,"eighty":-63.744655,"marketCap":2348275664},{"date":"2022-05-20","current":46.570623,"twenty":-506.659907,"median":-136.418578,"eighty":-63.235891,"marketCap":2256486388},{"date":"2022-05-27","current":46.570623,"twenty":-504.952792,"median":-134.732506,"eighty":-0.000033,"marketCap":2256486388},{"date":"2022-06-03","current":46.286463,"twenty":-504.481864,"median":-131.14577,"eighty":45.882325,"marketCap":2242717996},{"date":"2022-06-10","current":44.234198,"twenty":-503.06908,"median":-130.287406,"eighty":45.857066,"marketCap":2143279613},{"date":"2022-06-17","current":39.845509,"twenty":-502.068357,"median":-129.030516,"eighty":45.623424,"marketCap":1930634455},{"date":"2022-06-24","current":39.877082,"twenty":-501.832893,"median":-128.785269,"eighty":45.49713,"marketCap":1932164276},{"date":"2022-07-01","current":40.697988,"twenty":-501.538563,"median":-128.509366,"eighty":45.433984,"marketCap":1971939629},{"date":"2022-07-08","current":40.508549,"twenty":-500.361242,"median":-127.834937,"eighty":45.383466,"marketCap":1962760702},{"date":"2022-07-15","current":39.498203,"twenty":-499.831448,"median":-127.405755,"eighty":45.092992,"marketCap":1913806421},{"date":"2022-07-22","current":42.592387,"twenty":-499.537118,"median":-127.160508,"eighty":44.392065,"marketCap":2063728906},{"date":"2022-07-29","current":44.297345,"twenty":-499.242787,"median":-126.271488,"eighty":44.272087,"marketCap":2146339255},{"date":"2022-08-05","current":36.021023,"twenty":-498.477529,"median":-125.259845,"eighty":44.39838,"marketCap":2122322658},{"date":"2022-08-12","current":40.78048,"twenty":-498.065467,"median":-124.340169,"eighty":44.272087,"marketCap":2402745074},{"date":"2022-08-19","current":39.298026,"twenty":-497.535673,"median":-121.642453,"eighty":44.265772,"marketCap":2315400387},{"date":"2022-08-26","current":38.10166,"twenty":-497.182477,"median":-118.086373,"eighty":44.240513,"marketCap":2244911692},{"date":"2022-09-02","current":35.942999,"twenty":-496.652682,"median":-116.798827,"eighty":43.678508,"marketCap":2117725569},{"date":"2022-09-09","current":38.517787,"twenty":-496.53495,"median":-72.31223,"eighty":43.520642,"marketCap":2269429499},{"date":"2022-09-16","current":35.604896,"twenty":-496.358352,"median":-68.343875,"eighty":42.958637,"marketCap":2097804851},{"date":"2022-09-23","current":34.798649,"twenty":-496.064022,"median":-67.699442,"eighty":42.535555,"marketCap":2050301600},{"date":"2022-09-30","current":33.368211,"twenty":-495.063299,"median":-67.343308,"eighty":42.497667,"marketCap":1966021639},{"date":"2022-10-07","current":34.330506,"twenty":-493.41505,"median":-66.61408,"eighty":42.289283,"marketCap":2022719067},{"date":"2022-10-14","current":33.472243,"twenty":-492.355462,"median":-66.139234,"eighty":42.112472,"marketCap":1972151090},{"date":"2022-10-21","current":38.179684,"twenty":-490.354017,"median":-65.514401,"eighty":41.840942,"marketCap":2249508781},{"date":"2022-10-28","current":37.451461,"twenty":-487.587314,"median":-65.138666,"eighty":41.676761,"marketCap":2206602619},{"date":"2022-11-04","current":26.580134,"twenty":-485.997931,"median":-65.053873,"eighty":41.619929,"marketCap":1566074914},{"date":"2022-11-11","current":31.176487,"twenty":-485.291539,"median":-64.545109,"eighty":41.468377,"marketCap":1865694530},{"date":"2022-11-18","current":31.735024,"twenty":-484.702878,"median":-64.273769,"eighty":41.127385,"marketCap":1899119025},{"date":"2022-11-25","current":32.979037,"twenty":-484.23195,"median":-63.765005,"eighty":40.925316,"marketCap":1973564490},{"date":"2022-12-02","current":34.654646,"twenty":-483.525558,"median":-63.578459,"eighty":40.875858,"marketCap":2073837975},{"date":"2022-12-09","current":34.273826,"twenty":-482.642568,"median":-63.154489,"eighty":40.844815,"marketCap":2051048547},{"date":"2022-12-16","current":32.775933,"twenty":-482.112773,"median":-31.068498,"eighty":40.806761,"marketCap":1961410129},{"date":"2022-12-23","current":33.029813,"twenty":-481.995041,"median":26.580134,"eighty":40.747483,"marketCap":1976603081},{"date":"2022-12-30","current":33.004425,"twenty":-480.699988,"median":29.373938,"eighty":40.672729,"marketCap":1975083786},{"date":"2023-01-06","current":33.689901,"twenty":-476.22617,"median":31.227263,"eighty":40.571695,"marketCap":2016104756},{"date":"2023-01-13","current":34.070721,"twenty":-475.34318,"median":31.582696,"eighty":40.508549,"marketCap":2038894185},{"date":"2023-01-20","current":33.029813,"twenty":-473.930395,"median":31.696942,"eighty":40.497223,"marketCap":1976603081},{"date":"2023-01-27","current":34.781586,"twenty":-471.92895,"median":31.963516,"eighty":40.327941,"marketCap":2081434451},{"date":"2023-02-03","current":36.330255,"twenty":-471.04596,"median":32.026986,"eighty":40.203102,"marketCap":2174111459},{"date":"2023-02-10","current":34.172274,"twenty":-468.573586,"median":32.344336,"eighty":40.03916,"marketCap":2044971366},{"date":"2023-02-17","current":34.47693,"twenty":-466.807606,"median":32.509358,"eighty":39.902341,"marketCap":2063202908},{"date":"2023-02-24","current":34.273826,"twenty":-466.16008,"median":32.54744,"eighty":39.858138,"marketCap":2051048547},{"date":"2023-03-03","current":31.749088,"twenty":-465.748017,"median":32.522052,"eighty":39.844719,"marketCap":2051118068},{"date":"2023-03-10","current":29.804799,"twenty":-465.630285,"median":32.496664,"eighty":39.788151,"marketCap":1925509253},{"date":"2023-03-17","current":31.268734,"twenty":-465.277089,"median":32.115844,"eighty":39.693957,"marketCap":2020085302},{"date":"2023-03-24","current":31.93208,"twenty":-464.688429,"median":31.988904,"eighty":39.644105,"marketCap":2062940074},{"date":"2023-03-31","current":31.93208,"twenty":-459.684817,"median":31.988904,"eighty":39.553373,"marketCap":2062940074},{"date":"2023-04-06","current":30.056413,"twenty":-456.506051,"median":31.963516,"eighty":39.498203,"marketCap":1941764511},{"date":"2023-04-14","current":29.804799,"twenty":-454.857802,"median":31.93208,"eighty":39.472944,"marketCap":1925509253},{"date":"2023-04-20","current":29.942043,"twenty":-452.385429,"median":31.920643,"eighty":39.435056,"marketCap":1934375757},{"date":"2023-04-28","current":29.252813,"twenty":-448.323673,"median":31.840584,"eighty":39.397168,"marketCap":1889848715},{"date":"2023-05-05","current":27.979963,"twenty":-445.615836,"median":31.760412,"eighty":39.37191,"marketCap":1807617535},{"date":"2023-05-12","current":34.627744,"twenty":-147.945181,"median":31.75475,"eighty":39.340336,"marketCap":1853138367},{"date":"2023-05-19","current":36.321642,"twenty":-147.883869,"median":31.909206,"eighty":39.298026,"marketCap":1943789007},{"date":"2023-05-26","current":35.583731,"twenty":-147.785771,"median":31.93208,"eighty":39.2148,"marketCap":1904298937},{"date":"2023-06-02","current":37.387514,"twenty":-147.172654,"median":31.988904,"eighty":39.130248,"marketCap":2000830219},{"date":"2023-06-09","current":37.578825,"twenty":-146.743472,"median":32.090456,"eighty":39.068806,"marketCap":2011068386},{"date":"2023-06-16","current":38.125426,"twenty":-145.872845,"median":32.344336,"eighty":39.045238,"marketCap":2040320290},{"date":"2023-06-23","current":38.480717,"twenty":-144.867333,"median":32.496664,"eighty":39.00735,"marketCap":2059334027},{"date":"2023-06-30","current":42.033624,"twenty":-144.180641,"median":32.522052,"eighty":39.052531,"marketCap":2249471402},{"date":"2023-07-07","current":40.694451,"twenty":-144.082543,"median":32.572828,"eighty":39.298026,"marketCap":2177804237},{"date":"2023-07-14","current":42.088284,"twenty":-144.082543,"median":32.763238,"eighty":39.498203,"marketCap":2252396592},{"date":"2023-07-21","current":42.935515,"twenty":-144.033493,"median":32.801321,"eighty":39.76947,"marketCap":2297737043},{"date":"2023-07-28","current":41.596343,"twenty":-143.825033,"median":32.877485,"eighty":40.03916,"marketCap":2226069879},{"date":"2023-08-04","current":39.054648,"twenty":-143.579786,"median":32.991731,"eighty":40.327941,"marketCap":2090048526},{"date":"2023-08-11","current":45.395505,"twenty":-142.991194,"median":33.029813,"eighty":40.512933,"marketCap":2227194274},{"date":"2023-08-18","current":44.655683,"twenty":-142.75821,"median":33.080589,"eighty":40.708213,"marketCap":2190897105},{"date":"2023-08-25","current":40.54227,"twenty":-142.243191,"median":33.160148,"eighty":40.708213,"marketCap":1989084847},{"date":"2023-09-01","current":41.282092,"twenty":-141.679123,"median":33.248238,"eighty":40.78924,"marketCap":2025382016},{"date":"2023-09-08","current":39.595297,"twenty":-141.458401,"median":33.35134,"eighty":40.869406,"marketCap":1942624471},{"date":"2023-09-15","current":42.909702,"twenty":-141.127318,"median":33.472243,"eighty":40.869406,"marketCap":2105235787},{"date":"2023-09-22","current":41.311685,"twenty":-140.734923,"median":33.677207,"eighty":40.928085,"marketCap":2026833903},{"date":"2023-09-29","current":41.311685,"twenty":-140.550988,"median":33.784339,"eighty":41.003352,"marketCap":2026833903},{"date":"2023-10-06","current":41.548428,"twenty":-139.680361,"median":33.969169,"eighty":41.027593,"marketCap":2038448997},{"date":"2023-10-13","current":41.725986,"twenty":-139.079506,"median":34.045333,"eighty":41.282092,"marketCap":2047160317},{"date":"2023-10-20","current":40.54227,"twenty":-138.797473,"median":34.121498,"eighty":41.302101,"marketCap":1989084847},{"date":"2023-10-27","current":38.411581,"twenty":-138.6258,"median":34.173366,"eighty":41.295712,"marketCap":1884549001},{"date":"2023-11-03","current":39.21059,"twenty":-136.418578,"median":34.197662,"eighty":41.282092,"marketCap":1923749943},{"date":"2023-11-10","current":46.093814,"twenty":-136.418578,"median":34.273826,"eighty":41.295712,"marketCap":1964794899},{"date":"2023-11-17","current":47.322482,"twenty":-135.192343,"median":34.299214,"eighty":41.350372,"marketCap":2017168097},{"date":"2023-11-24","current":51.5781,"twenty":-134.456603,"median":34.299214,"eighty":41.400092,"marketCap":2198568106},{"date":"2023-12-01","current":52.803719,"twenty":-132.310693,"median":34.340248,"eighty":41.555151,"marketCap":2250811308},{"date":"2023-12-08","current":53.450573,"twenty":-130.741113,"median":34.434538,"eighty":41.676761,"marketCap":2278384109},{"date":"2023-12-15","current":55.22091,"twenty":-130.373242,"median":34.464236,"eighty":41.725986,"marketCap":2353846513},{"date":"2023-12-22","current":54.982595,"twenty":-130.299668,"median":34.600306,"eighty":41.884021,"marketCap":2343688113},{"date":"2023-12-29","current":56.514618,"twenty":-130.287406,"median":34.615807,"eighty":41.980485,"marketCap":2408992116},{"date":"2024-01-05","current":53.246303,"twenty":-130.287406,"median":34.654646,"eighty":42.033624,"marketCap":2269676909},{"date":"2024-01-12","current":53.654842,"twenty":-129.061171,"median":34.781586,"eighty":42.229065,"marketCap":2287091310},{"date":"2024-01-19","current":54.267651,"twenty":-129.012122,"median":34.802811,"eighty":42.424831,"marketCap":2313212911},{"date":"2024-01-26","current":56.174169,"twenty":-128.852711,"median":34.902681,"eighty":42.711712,"marketCap":2394480115},{"date":"2024-02-02","current":56.650798,"twenty":-128.766875,"median":35.073548,"eighty":43.006574,"marketCap":2414796916},{"date":"2024-02-09","current":56.650798,"twenty":-128.754613,"median":35.23857,"eighty":43.678508,"marketCap":2414796916},{"date":"2024-02-16","current":58.216866,"twenty":-128.558415,"median":35.287811,"eighty":44.369013,"marketCap":2481552119},{"date":"2024-02-23","current":58.965855,"twenty":-128.178282,"median":35.370824,"eighty":45.004587,"marketCap":2513478521},{"date":"2024-03-01","current":60.955523,"twenty":-127.883986,"median":35.433415,"eighty":45.380704,"marketCap":2273214322},{"date":"2024-03-08","current":62.551421,"twenty":-127.687789,"median":35.522046,"eighty":45.466766,"marketCap":2332730150},{"date":"2024-03-15","current":62.201102,"twenty":-127.552903,"median":35.578888,"eighty":45.920213,"marketCap":2319665700},{"date":"2024-03-22","current":62.045405,"twenty":-127.38123,"median":35.669916,"eighty":46.095098,"marketCap":2313859278},{"date":"2024-03-28","current":62.473572,"twenty":-127.258607,"median":35.85902,"eighty":46.248575,"marketCap":2329826939},{"date":"2024-04-05","current":59.94349,"twenty":-127.197295,"median":36.021023,"eighty":46.570623,"marketCap":2235472577},{"date":"2024-04-12","current":60.994447,"twenty":-126.890736,"median":36.151063,"eighty":47.312213,"marketCap":2274665928},{"date":"2024-04-19","current":57.841576,"twenty":-126.461554,"median":36.219194,"eighty":47.917463,"marketCap":2157085877},{"date":"2024-04-26","current":64.123991,"twenty":-126.302144,"median":36.287866,"eighty":49.788803,"marketCap":2391376011},{"date":"2024-05-03","current":64.591197,"twenty":-125.946536,"median":36.463158,"eighty":51.925359,"marketCap":2408799516},{"date":"2024-05-10","current":72.955782,"twenty":-125.517354,"median":36.554398,"eighty":53.028415,"marketCap":2368144672},{"date":"2024-05-17","current":73.090841,"twenty":-125.23532,"median":36.758923,"eighty":53.396101,"marketCap":2372528702},{"date":"2024-05-24","current":73.940735,"twenty":-125.174008,"median":37.048337,"eighty":53.586752,"marketCap":2400116245},{"date":"2024-05-31","current":72.062023,"twenty":-124.8184,"median":37.113785,"eighty":53.94082,"marketCap":2339133255},{"date":"2024-06-07","current":73.225035,"twenty":-123.19977,"median":37.387514,"eighty":54.14509,"marketCap":2376884630},{"date":"2024-06-14","current":74.298584,"twenty":-121.826388,"median":37.451461,"eighty":54.267651,"marketCap":2411732052},{"date":"2024-06-21","current":71.25686,"twenty":-121.67924,"median":37.503477,"eighty":55.030258,"marketCap":2312997688},{"date":"2024-06-28","current":69.646536,"twenty":-121.642453,"median":37.578825,"eighty":55.248146,"marketCap":2260726554},{"date":"2024-07-05","current":72.196216,"twenty":-121.642453,"median":37.715475,"eighty":55.391135,"marketCap":2343489183},{"date":"2024-07-12","current":70.988473,"twenty":-118.515555,"median":37.909907,"eighty":55.969899,"marketCap":2304285832},{"date":"2024-07-15","current":71.25686,"twenty":-118.343882,"median":37.967688,"eighty":56.051607,"marketCap":2312997688},{"date":"2024-08-02","current":76.177296,"twenty":-118.172209,"median":37.982658,"eighty":56.133315,"marketCap":2472715042},{"date":"2024-08-09","current":85.000861,"twenty":-117.559092,"median":38.10166,"eighty":56.501,"marketCap":2496645298},{"date":"2024-08-16","current":103.993647,"twenty":-117.166697,"median":38.175904,"eighty":56.548663,"marketCap":2551900115},{"date":"2024-08-23","current":109.8007,"twenty":-115.940463,"median":38.234746,"eighty":56.671225,"marketCap":2694399381},{"date":"2024-08-30","current":111.459858,"twenty":-97.716642,"median":38.405153,"eighty":57.701448,"marketCap":2735113457},{"date":"2024-09-06","current":112.881993,"twenty":-71.769549,"median":38.473244,"eighty":58.145711,"marketCap":2770011236},{"date":"2024-09-13","current":114.244873,"twenty":-69.449588,"median":38.517787,"eighty":58.557315,"marketCap":2803454941},{"date":"2024-09-20","current":117.385422,"twenty":-68.649134,"median":38.644697,"eighty":58.969477,"marketCap":2880520871},{"date":"2024-09-27","current":116.141054,"twenty":-67.828329,"median":38.699843,"eighty":59.94349,"marketCap":2849985314},{"date":"2024-10-04","current":117.029888,"twenty":-67.780844,"median":38.805615,"eighty":60.612989,"marketCap":2871796426},{"date":"2024-10-11","current":115.192963,"twenty":-67.665524,"median":38.863337,"eighty":60.986662,"marketCap":2826720128},{"date":"2024-10-18","current":117.6817,"twenty":-67.529854,"median":38.94479,"eighty":61.516033,"marketCap":2887791242},{"date":"2024-10-25","current":106.719407,"twenty":-67.455235,"median":38.961457,"eighty":61.726225,"marketCap":2618787526},{"date":"2024-10-31","current":110.808046,"twenty":-67.156761,"median":39.037946,"eighty":62.045405,"marketCap":2719118641},{"date":"2024-11-08","current":110.808046,"twenty":-66.715833,"median":39.071963,"eighty":62.278951,"marketCap":2719118641},{"date":"2024-11-15","current":628.179146,"twenty":-66.61408,"median":39.193994,"eighty":62.551421,"marketCap":3081846892},{"date":"2024-11-22","current":652.813623,"twenty":-66.545338,"median":39.319181,"eighty":63.18958,"marketCap":3202703633},{"date":"2024-11-29","current":676.744257,"twenty":-66.518929,"median":39.380028,"eighty":63.669251,"marketCap":3320107325},{"date":"2024-12-06","current":695.747996,"twenty":-65.915378,"median":39.435056,"eighty":64.201859,"marketCap":3413339667},{"date":"2024-12-13","current":687.30189,"twenty":-65.739007,"median":39.54675,"eighty":65.433103,"marketCap":3371903071},{"date":"2024-12-20","current":653.869386,"twenty":-65.557966,"median":39.636129,"eighty":70.478537,"marketCap":3207883208},{"date":"2024-12-27","current":665.482782,"twenty":-65.502641,"median":39.713669,"eighty":71.131613,"marketCap":3264858529},{"date":"2025-01-03","current":648.59057,"twenty":-65.372698,"median":39.844193,"eighty":71.417893,"marketCap":3181985335},{"date":"2025-01-10","current":614.454224,"twenty":-65.169192,"median":39.877082,"eighty":71.874152,"marketCap":3014512423},{"date":"2025-01-17","current":641.552148,"twenty":-65.081007,"median":40.092836,"eighty":72.196216,"marketCap":3147454838},{"date":"2025-01-24","current":648.238649,"twenty":-65.053873,"median":40.281131,"eighty":73.001379,"marketCap":3180258810},{"date":"2025-01-31","current":659.852045,"twenty":-65.053873,"median":40.494392,"eighty":73.135572,"marketCap":3237234131},{"date":"2025-02-07","current":668.298151,"twenty":-65.019955,"median":40.512677,"eighty":73.538153,"marketCap":3278670728},{"date":"2025-02-14","current":704.194102,"twenty":-64.612944,"median":40.54227,"eighty":73.717078,"marketCap":3454776264},{"date":"2025-02-21","current":659.500124,"twenty":-64.504408,"median":40.54227,"eighty":74.137552,"marketCap":3235507606},{"date":"2025-02-28","current":-25.465823,"twenty":-64.341604,"median":40.601372,"eighty":74.495402,"marketCap":2808192701},{"date":"2025-03-07","current":-21.116132,"twenty":-64.280552,"median":40.54227,"eighty":74.334369,"marketCap":2328539239},{"date":"2025-03-14","current":-19.920286,"twenty":-64.273769,"median":40.521574,"eighty":74.227014,"marketCap":2196669655},{"date":"2025-03-21","current":-21.950078,"twenty":-63.866758,"median":40.508549,"eighty":74.137552,"marketCap":2420500923},{"date":"2025-03-28","current":-22.374918,"twenty":-63.737871,"median":40.295927,"eighty":73.97652,"marketCap":2467349328},{"date":"2025-04-04","current":-23.09872,"twenty":-63.731088,"median":40.182296,"eighty":73.869165,"marketCap":2547165129},{"date":"2025-04-11","current":-21.76126,"twenty":-63.486882,"median":39.913747,"eighty":73.743917,"marketCap":2399679410},{"date":"2025-04-17","current":-21.698321,"twenty":-63.385129,"median":39.844851,"eighty":73.717078,"marketCap":2392738905},{"date":"2025-04-25","current":-22.469327,"twenty":-63.235891,"median":39.713669,"eighty":73.636562,"marketCap":2477760085},{"date":"2025-05-02","current":-22.769607,"twenty":-62.727128,"median":39.618689,"eighty":73.582885,"marketCap":2510872849},{"date":"2025-05-09","current":-20.840532,"twenty":-62.259066,"median":39.498203,"eighty":73.556046,"marketCap":3096048609},{"date":"2025-05-16","current":-21.346933,"twenty":-40.134279,"median":39.426398,"eighty":73.484476,"marketCap":3171279004},{"date":"2025-05-23","current":-20.388308,"twenty":-24.357111,"median":39.37191,"eighty":73.395014,"marketCap":3028866694},{"date":"2025-05-30","current":-19.908996,"twenty":-23.606154,"median":39.298026,"eighty":73.305551,"marketCap":2957660539},{"date":"2025-06-06","current":-21.194956,"twenty":-23.582132,"median":39.157903,"eighty":73.18925,"marketCap":3148701443},{"date":"2025-06-13","current":-21.27679,"twenty":-23.559328,"median":39.056177,"eighty":73.135572,"marketCap":3160858591},{"date":"2025-06-20","current":-20.166188,"twenty":-23.510972,"median":39.037946,"eighty":73.126626,"marketCap":2995868720}],"updateTime":1750637616184}}}